Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Carriage of multidrug-resistant bacteria and nosocomial infections in intensive care unit patients: Experience at Ibn Tofail Hospital

Breadcrumb

  • Home
  • Carriage of Multidrug-resistant Bacteria and Nosocomial Infections In Intensive Care Unit Patients: Experience At Ibn Tofail Hospital
  • Carriage of multidrug-resistant bacteria and nosocomial infections in intensive care unit patients: Experience at Ibn Tofail Hospital

Moustahfid Nouhaila 1, 2, *, El_ghazouani Zakaria 1, 2, Debbagh Fayrouz 1, 2 and Zahlane Kawtar 1, 2

1 Microbiology Laboratory of Ibn Tofail Hospital of Marrakech, Morocco.

2 Faculty of Medicine and Pharmacy of Marrakesh.

Research Article
GSC Biological and Pharmaceutical Sciences, 2026, 34(01), 092-097.
Article DOI: 10.30574/gscbps.2026.34.1.0005
DOI url: https://doi.org/10.30574/gscbps.2026.34.1.0005

Received on 15 November 2025; revised on 07 January 2026; accepted on 10 January 2026

methods: This is a descriptive study conducted in the microbiology department of the Ibn Tofail Hospital at the Mohamed VI University Hospital in Marrakech over a four-month period from January to May 2024. It included biological and environmental samples received by the microbiology laboratory from patients hospitalized in the intensive care unit at Ibn Tofail Hospital who had developed nosocomial infections caused by multidrug-resistant (MDR) bacteria. Microorganism identification and antibiotic susceptibility testing were performed using standard bacteriological methods, supplemented by biochemical identification panels (BioMérieux, France). Antimicrobial resistance profiles were determined by the agar diffusion method, in accordance with EUCAST standards.

Results: During this period, 45 patients developed nosocomial infections within 48 hours of admission. The mean age of patients was 42 years, with a predominance of males (sex ratio = 2.46). All patients were exposed to at least one invasive procedure, such as tracheal intubation (97%), open surgery (93%), and arterial and urinary catheterization (91%).

The laboratory received 138 samples, with a positive culture rate of 75.4%. Multidrug-resistant bacteria were isolated in 68% of cases, mainly represented by imipenem-resistant Acinetobacter baumannii (IRAB) in 90 isolates (87%), followed by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL) (13%). Enterobacter cloacae dominated ESBL-producing isolates with 48%, followed by Escherichia coli (35%) and Klebsiella pneumoniae (17%).

A total of 180 samples were collected from the patients' environment. Seventy-two of the samples from the patients' environment were positive (40%) for MDR bacteria. Bed rails had the highest number of positive samples (38%), followed by the respiratory system (29%) and door handles (19%). Imipenem-resistant Acinetobacter baumannii was predominant (96%).

Conclusion: Detecting multidrug-resistant bacterial colonization plays a key role in controlling and preventing healthcare-associated infections. Strengthening surveillance systems, improving diagnostic techniques, and raising awareness among healthcare workers are essential strategies for mitigating the impact of antimicrobial resistance and ensuring better outcomes for patients.

Multidrug-resistant bacteria; Nosocomial infections; Intensive care unit

https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2026-…

Preview Article PDF

Moustahfid Nouhaila, El_ghazouani Zakaria, Debbagh Fayrouz and Zahlane Kawtar. Carriage of multidrug-resistant bacteria and nosocomial infections in intensive care unit patients: Experience at Ibn Tofail Hospital. GSC Biological and Pharmaceutical Sciences, 2026, 34(1), 092-097. Article DOI: https://doi.org/10.30574/gscbps.2026.34.1.0005


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution